Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $0.24 in the prior trading day, GlycoMimetics Inc (NASDAQ: GLYC) closed at $0.23, down -6.31%. In other words, the price has decreased by -$6.31 from its previous closing price. On the day, 0.54 million shares were traded.
Ratios:
Our goal is to gain a better understanding of GLYC by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.29 and its Current Ratio is at 2.29. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On December 22, 2023, CapitalOne started tracking the stock assigning a Overweight rating and target price of $12.CapitalOne initiated its Overweight rating on December 22, 2023, with a $12 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 08 ’24 when Invus Public Equities, L.P. sold 260,873 shares for $0.19 per share. The transaction valued at 50,009 led to the insider holds 6,317,565 shares of the business.
Invus Public Equities, L.P. sold 61,488 shares of GLYC for $11,197 on Aug 07 ’24. The 10% Owner now owns 6,578,438 shares after completing the transaction at $0.18 per share. On Aug 05 ’24, another insider, Invus Public Equities, L.P., who serves as the 10% Owner of the company, sold 164,523 shares for $0.19 each. As a result, the insider received 30,996 and left with 6,695,658 shares of the company.
Stock Price History:
Over the past 52 weeks, GLYC has reached a high of $0.63, while it has fallen to a 52-week low of $0.14. The 50-Day Moving Average of the stock is -3.56%, while the 200-Day Moving Average is calculated to be -6.46%.
Shares Statistics:
A total of 64.53M shares are outstanding, with a floating share count of 56.12M. Insiders hold about 13.04% of the company’s shares, while institutions hold 43.01% stake in the company.
Earnings Estimates
The company has 1.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.02 and -$0.02 for the fiscal current year, implying an average EPS of -$0.02. EPS for the following year is -$0.03, with 1.0 analysts recommending between -$0.03 and -$0.03.
